Similar articles

• The carrier potential of liposomes in biology and medicine (second of two parts).

  Gregoriadis G. Gregoriadis G. N Engl J Med. 1976 Sep 30;295(14):765-70. doi: 10.1056/NEJM197609302951406. N Engl J Med. 1976. PMID: 785256 Review. No abstract available.
• Immunologic aspects of enzyme replacement therapy. An evaluation of the immune response to unentrapped, erythrocyte- and liposome-entrapped enzyme in C3H/HeJ Gush mice.

  Hudson LD, Fiddler MB, Desnick RJ. Hudson LD, et al. Birth Defects Orig Artic Ser. 1980;16(1):163-78. Birth Defects Orig Artic Ser. 1980. PMID: 6778523
• Adjuvant formulations for experimental vaccines.

  Stewart-Tull DE. Stewart-Tull DE. Methods Mol Med. 2003;87:175-94. doi: 10.1385/1-59259-399-2:175. Methods Mol Med. 2003. PMID: 12958456 No abstract available.
• Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.

  Vasantha S, Antony A, Lal SM. Vasantha S, et al. Acta Virol. 1987 Mar;31(2):109-15. Acta Virol. 1987. PMID: 2886019
• Vaccine entrapment in liposomes.

  Gregoriadis G, McCormack B, Obrenovic M, Saffie R, Zadi B, Perrie Y. Gregoriadis G, et al. Methods. 1999 Sep;19(1):156-62. doi: 10.1006/meth.1999.0841. Methods. 1999. PMID: 10525452 Review.